March 2008 Volume 22 Number 3, pp 463 - 672
--------------------------------------------------------------------
Natureevents Directory 2008
The FREE digital edition of the Natureevents Directory 2008 is now
available.
Click here to download the complete resource for global scientific
events and start planning your conference attendance for the year
ahead.
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bnf80EH
----------------------------------------------------------------------
Cell Death & Differentiation Special Issue on Immunity
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bm580ER
In this issue of CDD, several reviews focus on the role of death, at
the cellular level, in immunity.
Select reviews on:
- NK cells at the interface between innate and adaptive immunity
- Apoptosis and the immune system
- Clearance of apoptotic cells by phagocytes
- Mechanisms of granule-dependent killing
Visit CDD online to view these articles
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bm580ER
----------------------------------------------------------------------
Why Publish in Leukemia?
Efficient peer-review, hassle-free submission, recognition...
Papers benefit from wide readership through hosting on nature.com and
inclusion in the leading abstracting and indexing services.
Rapid publication is also assured through Advance Online Publication.
To read the full Guide to Authors for Leukemia, visit
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BIHy0EF
----------------------
EDITORIAL
----------------------
Mesenchymal stem cells for graft-versus-host disease: a double edged
sword?
F Vianello and F Dazzi
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwH0Eq
----------------------
SPOTLIGHT REVIEWS
----------------------
Chemokine-mobilized adult stem cells; defining a better hematopoietic
graft
L M Pelus and S Fukuda
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwI0Er
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwJ0Es
Choosing between stem cell therapy and drugs in myelofibrosis
N Kroger and R A Mesa
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwK0Et
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwL0Eu
----------------------
REVIEW
----------------------
Splenic marginal zone lymphoma proposals for a revision of diagnostic,
staging and therapeutic criteria
E Matutes, D Oscier, C Montalban, F Berger, E Callet-Bauchu, A Dogan,
P Felman, V Franco, E Iannitto, M Mollejo, T Papadaki, E D Remstein, A
Salar, F Sole, K Stamatopoulos, C Thieblemont, A Traverse-Glehen, A
Wotherspoon, B Coiffier and M A Piris
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwM0Ev
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwN0Ew
----------------------
ORIGINAL ARTICLES
----------------------
Novel antifungal agents as salvage therapy for invasive aspergillosis
in patients with hematologic malignancies: posaconazole compared with
high-dose lipid formulations of amphotericin B alone or in combination
with caspofungin
I I Raad, H A Hanna, M Boktour, Y Jiang, H A Torres, C Afif, D P
Kontoyiannis and R Y Hachem
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwO0Ex
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwP0Ey
Bone marrow fibrosis in childhood acute lymphoblastic leukemia
correlates to biological factors, treatment response and outcome
U Noren-Nystrom, G Roos, A Bergh, J Botling, G Lonnerholm, A Porwit, M
Heyman and E Forestier
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwQ0Ez
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwR0E1
Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4
cell line: rescue of CD44-dependent cell death by cAMP
I Abecassis, J Maes, J-L Carrier, J Hillion, M Goodhardt, K Medjber, L
Wany, M Lanotte and A Karniguian
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwS0E2
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwT0E3
The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia
biology and therapy
Y Ge, K M LaFiura, A A Dombkowski, Q Chen, S G Payton, S A Buck, S
Salagrama, A E Diakiw, L H Matherly and J W Taub
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwU0E4
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwV0E5
Immunophenotypic, cytogenetic and functional characterization of
circulating endothelial cells in myelodysplastic syndromes
M G Della Porta, L Malcovati, G M Rigolin, V Rosti, E Bonetti, E
Travaglino, E Boveri, A Galli, S Boggi, M Ciccone, T Pramparo, G
Mazzini, R Invernizzi, M Lazzarino and M Cazzola
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwW0E6
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwX0E7
A prognostic score for patients with lower risk myelodysplastic
syndrome
G Garcia-Manero, J Shan, S Faderl, J Cortes, F Ravandi, G Borthakur, W
G Wierda, S Pierce, E Estey, J Liu, X Huang and H Kantarjian
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwY0E8
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpwZ0EA
Comparison of hypoplastic myelodysplastic syndrome (MDS) with
normo-//hypercellular MDS by International Prognostic Scoring System,
cytogenetic and genetic studies
T-C Huang, B-S Ko, J-L Tang, C Hsu, C-Y Chen, W Tsay, S-Y Huang, M
Yao, Y-C Chen, M-C Shen, C-H Wang and H-F Tien
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwa0EH
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwb0EI
Base excision repair dysfunction in a subgroup of patients with
myelodysplastic syndrome
A M Jankowska, L P Gondek, H Szpurka, Z P Nearman, R V Tiu and J P
Maciejewski
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwc0EJ
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwd0EK
Subcellular distribution of p210BCR-ABL in CML cell lines and primary
CD34+ CML cells
H Patel, S B Marley, L Greener and M Y Gordon
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwe0EL
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwf0EM
Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition
with U0126, rapamycin and Bcl-2 inhibitor GX15-070
S Dong, S Kang, S Lonial, H J Khoury, J Viallet and J Chen
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwg0EN
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwh0EO
HLA-G turns off erythropoietin receptor signaling through JAK2 and
JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera
C Menier, C Guillard, B Cassinat, E D Carosella and N Rouas-Freiss
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwi0EP
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwj0EQ
Targeting lipid metabolism by the lipoprotein lipase inhibitor
orlistat results in apoptosis of B-cell chronic lymphocytic leukemia
cells
C P Pallasch, J Schwamb, S Konigs, A Schulz, S Debey, D Kofler, J L
Schultze, M Hallek, A Ultsch and C-M Wendtner
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwk0ER
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwl0ES
The correlation between cotransplantation of mesenchymal stem cells
and higher recurrence rate in hematologic malignancy patients: outcome
of a pilot clinical study
H Ning, F Yang, M Jiang, L Hu, K Feng, J Zhang, Z Yu, B Li, C Xu, Y
Li, J Wang, J Hu, X Lou and H Chen
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwm0ET
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwn0EU
MEF2C is activated by multiple mechanisms in a subset of T-acute
lymphoblastic leukemia cell lines
S Nagel, C Meyer, H Quentmeier, M Kaufmann, H G Drexler and R A F
MacLeod
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwo0EV
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwp0EW
T-cell lymphomas in T-cell-specific Pten-deficient mice originate in
the thymus
T J Hagenbeek and H Spits
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwq0EX
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwr0EY
Cell origin of pyothorax-associated lymphoma: a lymphoma strongly
associated with Epstein-Barr virus infection
T Takakuwa, K Tresnasari, N Rahadiani, H Miwa, M Daibata and K Aozasa
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpws0EZ
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwt0Ea
----------------------
LETTERS TO THE EDITOR
----------------------
Vorinostat and bortezomib significantly inhibit WT1 gene expression in
MO7-e and P39 cell lines
S Galimberti, M Canestraro, R Khan, G Buda, E Orciuolo, F Guerrini, R
Fazzi, R Maffei, R Marasca and M Petrini
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwu0Eb
Platelet transfusion and survival in adults with acute leukemia
N Blumberg, J M Heal, J L Liesveld, G L Phillips and J M Rowe
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwv0Ec
The immunomodulatory drug Leflunomide inhibits cell cycle progression
of B-CLL cells
I Ringshausen, M Oelsner, C Bogner, C Peschel and T Decker
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpww0Ed
Chromosomal localization of DNA methylation in small B-cell lymphoma
K H Taylor, F Rahmatpanah, J W Davis and C W Caldwell
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwx0Ee
Non-specific amplification of patient-specific Ig//TCR gene
rearrangements depends on the time point during therapy: implications
for minimal residual disease monitoring
V H J van der Velden, J M Wijkhuijs and J J M van Dongen
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwy0Ef
A novel cytogenetic aberration found in stem cell leukemia//lymphoma
syndrome
L Shvidel, E Sigler, E Vorst, E Feldberg, N Voskoboinic, M Shtalrid
and A Berrebi
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpwz0Eg
Pulmonary arterial hypertension in primary myelofibrosis is common and
associated with an altered angiogenic status
A Cortelezzi, G Gritti, N Del Papa, M C Pasquini, R Calori, U
Gianelli, M Cortiana, G Parati, F Onida, F Sozzi, C Vener, P Bianchi
and G L Deliliers
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpw10ET
Comparison of nilotinib and imatinib inhibition of FMS receptor
signaling, macrophage production and osteoclastogenesis
N Brownlow, A E Russell, H Saravanapavan, M Wiesmann, J M Murray, P W
Manley and N J Dibb
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpw20EU
Acute myeloid leukemia-targeted toxins kill tumor cells by cell
type-specific mechanisms and synergize with TRAIL to allow
manipulation of the extent and mechanism of tumor cell death
H Horita, A E Frankel and A Thorburn
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpw30EV
Recurrent in-frame insertion in C/EBP[alpha] TAD2 region is a
polymorphism without prognostic value in AML
V Biggio, A Renneville, O Nibourel, N Philippe, L Terriou, C Roumier,
P Amouyel, D Cottel, S Castaigne, H Dombret, X Thomas, P Fenaux and C
Preudhomme
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpw40EW
Multiple forms of nuclear p53 formed in human Raji and MEC1 cells
treated with fludarabine
S Henrich and R I Christopherson
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpw50EX
MassARRAY assay: a more accurate method for JAK2V617F mutation
detection in Chinese patients with myeloproliferative disorders
J-F Fu, J-Y Shi, W-L Zhao, G Li, Q Pan, J-M Li, J Hu, Z-X Shen, J Jin,
F-Y Chen and S-J Chen
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpw60EY
NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid
leukemia
S Esteyries, C Perot, J Adelaide, M Imbert, A Lagarde, C Pautas, S
Olschwang, D Birnbaum, M Chaffanet and M-J Mozziconacci
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpw70EZ
CREB regulates Meis1 expression in normal and malignant hematopoietic
cells
S D Esparza, J Chang, D B Shankar, B Zhang, S F Nelson and K M
Sakamoto
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20Bpw80Ea
Mcl-1 and anticancer vaccination: identification of an
HLA-A2-restricted epitope
R S Andersen, L Wenandy, R B Sorensen, P thor Straten and M H Andersen
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpxA0Ek
No role for CXCL12-G801A polymorphism in the development of
extramedullary disease in acute myeloid leukemia
V Ponziani, F Mannelli, N Bartalucci, G Gianfaldoni, F Leoni, E
Antonioli, P Guglielmelli, S Ciolli, A Bosi and A M Vannucchi
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpxB0El
----------------------
CORRIGENDUM
----------------------
Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB
chimaera responded to imatinib mesylate therapy
K Tokita, K Maki, J Tadokoro, Y Nakamura, Y Arai, K Sasaki, M
Eguchi-Ishimae, M Eguchi and K Mitani
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BpxC0Em
------------------------------------------------------------------------
Ensure your access
If you are unable to access the articles in this Table of Contents
e-alert, your library may not subscribe to this journal.
Our online recommendation form is a simple way to make your
librarian aware that this journal is valuable to your research.
Recommend now at
http://ealerts.nature.com/cgi-bin24/DM/y/ejen0Xztnp0Hi20BTiM0EF
======================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
(c) Copyright 2008 Nature Publishing Group
======================================================================
